Clinical trials
Withdrawn Diabetes Mellitus, Type 1 trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
111 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 3 |
| 2007 | 1 |
| 2008 | 7 |
| 2009 | 8 |
| 2010 | 3 |
| 2011 | 7 |
| 2012 | 6 |
| 2013 | 4 |
| 2014 | 3 |
| 2015 | 6 |
| 2016 | 7 |
| 2017 | 5 |
| 2018 | 10 |
| 2019 | 7 |
| 2021 | 10 |
| 2022 | 4 |
| 2023 | 6 |
| 2024 | 1 |
| 2025 | 4 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 111 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Institut de Recherches Cliniques de Montreal | 6 |
| Medtronic MiniMed, Inc. | 5 |
| Vanderbilt University | 4 |
| Eli Lilly and Company | 3 |
| Stanford University | 3 |
| Children's Mercy Hospital Kansas City | 2 |
| Emory University | 2 |
| Insel Gruppe AG, University Hospital Bern | 2 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 2 |
| Novartis Pharmaceuticals | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 1 | 111 |
| Diabetes Mellitus | 25 |
| Diabetes Mellitus, Type 2 | 17 |
| Hypoglycemia | 16 |
| Insulin Resistance | 8 |
| Hyperglycemia | 4 |
| Autoimmune Diseases | 3 |
| Endocrine System Diseases | 3 |
| Diabetic Retinopathy | 2 |
| Foot Ulcer | 2 |
Trials
Showing 76 to 100 of 111. Each trial links to its page on Pharma Observatory.
11 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.